Generation of transgenic animals

Target Validation in Drug Discovery

Volumn , Issue , 2007, Pages 3-26

  Zambrowicz, Brian P ^a   Holt, Kathleen H ^a   Wade Walke, D ^a   Kirkpatrick, Laura L ^a   Eberhart, Derek E ^a  

^a LEXICON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 53849130016     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369393-8/50002-X     Document Type: Chapter

References (61)

1. MGI: Genome Informatics (MGI) provides integrated access to data on the genetics, genomics, and biology of the laborator. http://www.informatics.jax.org/Mouse.
2. UCSC Genome Bioinformatics: Ensembl: . http://www.ensembl.org/index.html.
3. NCBI:. http://www.ncbi.nlm.nih.gov/.
4. Austin C.P., Battey J.F., et al. The knockout mouse project. Nat. Genet. 2004, 36(9):921-924.
5. Balling R. ENU mutagenesis, analyzing gene function in mice. Annu. Rev. Genomics Hum. Genet. 2001, 2:463-492.
6. Bradley A., Evans M., et al. Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 1984, 309(5965):255-256.
7. Bridge A.J., Pebernard S., et al. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 2003, 34(3):263-264.
8. Chang H.S., Lin C.H., et al. Using siRNA technique to generate transgenic animals with spatiotemporal and conditional gene knockdown. Am. J. Pathol. 2004, 165(5):1535-1541.
9. Cuenot L. Notes et revues. Arch Zool. Exp. Gen. 1902, xxvii.
10. Deng C., Capecchi M.R. Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus. Mol. Cell Biol. 1992, 12(8):3365-3371.
11. Dykxhoorn D.M., Novina C.D., et al. Killing the messenger, Short RNAs that silence gene expression. Nat. Rev. Mol. Cell Biol. 2003, 4(6):457-467.
12. Forrester L.M., Nagy A., et al. An induction gene trap screen in embryonic stem cells, Identification of genes that respond to retinoic acid in vitro. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:1677-1682. 4.
13. Giaever G., Chu A.M., et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature 2002, 418(6896):387-391.
14. Gorer P.Z. Further studies on antigenetic differences in mouse erythrocytes. Br. J. Exp. Pathol. 1937, 18:31-36.
15. Gorer P.Z. The genetic and antigenetic basis of tumour transplantation. J. Pathol. Bacteriol. 1937, 44:691-697.
16. Guenet J.L. Chemical mutagenesis of the mouse genome, an overview. Genetica 2004, 122(1):9-24.
17. Hasty P., Rivera-Perez J., et al. The length of homology required for gene targeting in embryonic stem cells. Mol. Cell Biol. 1991, 11(11):5586-5591.
18. Hemann M.T., Fridman J.S., et al. An epi-allelic series of p53hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat. Genet. 2003, 33(3):396-400.
19. Hentges K.E., Justice M.J. Checks and balancers, balancer chromosomes to facilitate genome annotation. Trends Genet. 2004, 20(6):252-259.
20. Hrabe de Angelis M.H., Flaswinkel H., et al. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat. Genet. 2000, 25(4):444-447.
21. Hubbard S.C., Walls L., et al. Generation of Chinese hamster ovary cell glycosyla-tion mutants by retroviral insertional mutagenesis. Integration into a discrete locus gener-ates mutants expressing high levels of N-glycolylneuraminic acid. J. Biol. Chem. 1994, 269(5):3717-3724.
22. Jackson A.L., Bartz S.R., et al. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 2003, 21(6):635-637.
23. Joyner A.L. Gene targeting, a practical approach 1999, Oxford University Press, New York.
24. Justice M.J., Noveroske J.K., et al. Mouse ENU mutagenesis. Hum. Mol. Genet. 1999, 8(10):1955-1963.
25. Kamath R.S., Fraser A.G., et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 2003, 421(6920):231-237.
26. Kim D.H., Behlke M.A., et al. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 2005, 23(2):222-226.
27. Kunath T., Gish G., et al. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat. Biotechnol. 2003, 21(5):559-561.
28. Lander E.S., Linton L.M., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409(6822):860-921.
29. Lee E.C., Yu D., et al. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 2001, 73(1):56-65.
30. Lickert H., Takeuchi J.K., et al. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 2004, 432(7013):107-112.
31. Mansour S.L., Thomas K.R., et al. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells, A general strategy for targeting mutations to non-selectable genes. Nature 1988, 336(6197):348-352.
32. Mulbock O., Bentvelzen P. The transmission of the mammary tumor viruses. Perspect Virol. 1968, 6:75-87.
33. Nolan P.M., Peters J., et al. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat. Genet. 2000, 25(4):440-443.
34. O'Brien T.P., Frankel W.N. Moving forward with chemical mutagenesis in the mouse. J. Physiol. 2004, 554:13-21. Pt 1.
35. Paigen K. One hundred years of mouse genetics, An intellectual history. II. The molecular revolution 1981-1902). Genetics 2003, 163(4):1227-1235.
36. Rubinson D.A., Dillon C.P., et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 2003, 33(3):401-406.
37. Scacheri P.C., Rozenblatt-Rosen O., et al. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:1892-1897. 7.
38. Schnutgen F., De-Zolt S., et al. Genomewide production of multipurpose alleles for the functional analysis of the mouse genome. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:7221-7226. 20.
39. Shigeoka T., Kawaichi M., et al. Suppression of nonsense-mediated mRNA decay permits unbiased gene trapping in mouse embryonic stem cells. Nucleic Acids Res. 2005, 33(2):e20.
40. Skarnes W.C., Melchner H.von, et al. A public gene trap resource for mouse functional genomics. Nat. Genet. 2004, 36(6):543-544.
41. Sledz C.A., Holko M., et al. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 2003, 5(9):834-839.
42. Staats J. Standardized nomenclature for inbred strains of mice, Seventh listing for the International Committee on Standardized Genetic Nomenclature for Mice. Cancer Res. 1980, 40(7):2083-2128.
43. Stanford W.L., Caruana G., et al. Expression trapping, Identification of novel genes expressed in hematopoietic and endothelial lineages by gene trapping in ES cells. Blood 1998, 92(12):4622-4631.
44. Stanford W.L., Cohn J.B., et al. Gene-trap mutagenesis, Past, present and beyond. Nat. Rev. Genet. 2001, 2(10):756-768.
45. te Riele, Maandag H.E.R., et al. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:5128-5132. 11.
46. Uprichard S.L., Boyd B., et al. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:773-778. 3.
47. Valenzuela D.M., Murphy A.J., et al. High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat. Biotechnol. 2003, 21(6):652-659.
48. Venter J.C., Adams M.D., et al. The sequence of the human genome. Science 2001, 291(5507):1304-1351.
49. Ventura A., Meissner A., et al. Cre-lox-regulated conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10380-10385. 28.
50. Waterston R.H., Lindblad-Toh K., et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002, 420(6915):520-562.
51. Wattler S., Kelly M., et al. Construction of gene targeting vectors from lambda KOS genomic libraries. Biotechniques 1999, 26(6):1150-1156.
52. Wattler S., Kelly M., et al. Construction of gene targeting vectors from lambda KOS genomic libraries. Biotechniques 1999, 26(6):1158.
53. Wattler S., Kelly M., et al. Construction of gene targeting vectors from lambda KOS genomic libraries. Biotechniques 1999, 26(6):1160.
54. Wiles M.V., Vauti F., et al. Establishment of a gene-trap sequence tag library to generate mutant mice from embryonic stem cells. Nat. Genet. 2000, 24(1):13-14.
55. Xia H., Mao Q., et al. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat. Med. 2004, 10(8):816-820.
56. Xin H.B., Deng K.Y., et al. Gene trap and gene inversion methods for conditional gene inactivation in the mouse. Nucleic Acids Res. 2005, 33(2):e14.
57. Zambrowicz B.P., Abuin A., et al. Wnk1 kinase deficiency lowers blood pressure in mice, A gene-trap screen to identify potential targets for therapeutic intervention. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:14109-14114. 24.
58. Zambrowicz B.P., Friedrich G.A. Comprehensive mammalian genetics, History and future prospects of gene trapping in the mouse. Int. J. Dev. Biol. 1998, 42(7):1025-1036.
59. Zambrowicz B.P., Friedrich G.A., et al. Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells. Nature 1998, 392(6676):608-611.
60. Zambrowicz B.P., Sands A.T. Knockouts model the 100 best-selling drugs-will they model the next 100?. Nat. Rev. Drug. Discov. 2003, 2(1):38-51.
61. Zambrowicz B.P., Turner C.A., et al. Predicting drug efficacy, Knockouts model pipeline drugs of the pharmaceutical industry. Curr. Opin. Pharmacol. 2003, 3(5):563-570.